CSF1 and Alzheimer disease: These data are consistent with animal studies showing a marked increase in CSF1 mRNA levels in microglia from Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), and MS preclinical mouse models (Supplementary Fig. 1D).